Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE).
Gianluca IngrossoElisabetta PontiGiulio FrancoliniSaverio CainiSimona FondelliRoberto SantiniMaurizio ValerianiLuciana RagoGiacomo DuroniAlessio BruniAntonietta AugurioFrancesco TramacereFabio TrippaDonatella RussoMarta BotteroMaria TamburoSilvana ParisiSimona BorghesiAndrea LanciaSara GomelliniSilvia ScocciantiMarco StefanacciGianluca VulloTeodora StatutoGiulia MirandaBianca SantoAlessandro Di MarzoRita BellavitaAnnamaria VinciguerraLorenzo LiviCynthia AristeiNiccolò BertiniCarolina OrsattiBeatrice DettiPublished in: La Radiologia medica (2024)
Real-world long-term results of this multicentric study on cutting-edge techniques for the cure of localized PCa demonstrated an excellent biochemical-free survival rate of 85.5% at 15 years, and very low rates of ≥ G3 late GU and GI toxicity (1.6% and 0.9% respectively), strengthening the results of the available published trials.